from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1303/-

LFCtreatmentdescriptionclass of inhibitor

-0.252

Amikacinug/mL Amikacintranslation

0.118

Cap5-10ug/mL Capreomycintranslation

0.213

Rox10-50 ug/mL Roxithromycintranslation

0.111

SM2-5 ug/mL Streptomycintranslation

-0.017

Tet5-10 ug/mL Tetracyclinetranslation

-1.551

Rif0.2-5ug/mL Rifampicintranscription

0.075

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.132

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.591

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.112

CPZ10-50 ug/mL Chlorpromazinerespiration

0.183

Clofazimine10-13 ug/mL Clofaziminerespiration

0.350

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.153

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.077

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.738

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.603

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.693

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.274

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.683

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.037

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.712

KCN5-20 ug/mL Potassium cyaniderespiration

1.220

NaN30.2-2 mM Sodium aziderespiration

0.237

Nigericin50 uM Nigericinrespiration

-1.104

TRC10-150 ug/mL Triclosanrespiration

-1.482

TRZ10-25 ug/mL Thioridazinerespiration

-2.447

Valinomycin0.5-10 uM Valinomycinrespiration

0.950

ZnSO42 mM ZnSO4respiration

-1.325

menadione6-10 ug/mL Menadionerespiration

0.238

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.130

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.247

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.466

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.444

NRP_1Non-replicating persistence stage 1dosRassociated

0.753

Amp0.2mg/mL AmpicillincellWall

0.171

Cephalexin20-100 ug/mL CephalexincellWall

0.341

Cerulenin0.32-5 ug/mL CerulenincellWall

0.414

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.135

EMB10-20 ug/mL EthambutolcellWall

0.993

Eta12-40 ug/mL EthionamidecellWall

1.090

INH0.2-0.4 ug/mL IsoniazidcellWall

0.736

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.353

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.561

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.976

BZA0.12 mg/mL BenzamidearomaticAmides

0.214

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.368

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.585

H2O24 mM hydrogen peroxideDNAdamaging

0.996

Levo10 ug/mL LevofloxacinDNAdamaging

0.767

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.435

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.955

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.890

UVUV-irradiationDNAdamaging

-1.476

ARP41-4 ug/mL Antitubercular compound ARP4?

0.186

Antimycin12.5-50 ug/mL Antimycin A?

0.062

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.354

PA_110-50 ug/mL Antitubercular compound PA-1?

0.463

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.107

PA8240.2-2 ug/mL PA-824?

-0.172

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.100

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.420

Verapamil50 uM Verapamil?

0.100

mercaptoethanol2 mM 2-Mercaptoethanol?

0.217

methoxatin10-20 ug/mL Methoxatin?